119 related articles for article (PubMed ID: 3839860)
1. Vasoconstrictor effect of neuropeptide Y (NPY) on canine coronary artery.
Aizawa Y; Murata M; Hayashi M; Funazaki T; Ito S; Shibata A
Jpn Circ J; 1985 Jun; 49(6):584-8. PubMed ID: 3839860
[TBL] [Abstract][Full Text] [Related]
2. Effect of nifedipine on neuropeptide Y-induced coronary vasoconstriction in anesthetized dogs.
Hayashi M; Aizawa Y; Satoh M; Suzuki K; Shibata A
Jpn Heart J; 1986 Mar; 27(2):251-7. PubMed ID: 3755186
[TBL] [Abstract][Full Text] [Related]
3. Potency and receptors involved in coronary vasoconstriction caused by neuropeptide Y(NPY).
Aizawa Y; Satoh M; Aizawa M; Funazaki T; Niwano S; Miyajima S; Shibata A
Jpn Heart J; 1987 Nov; 28(6):891-8. PubMed ID: 2832630
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of the vasoconstrictor action of neuropeptide-Y by calcium-channel blockers.
Aizawa Y; Niwano S; Aizawa M; Tamura M; Shibata A
Angiology; 1989 Oct; 40(10):890-4. PubMed ID: 2802259
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y (NPY): a coronary vasoconstrictor and potentiator of catecholamine-induced coronary constriction.
Macho P; Pérez R; Huidobro-Toro JP; Domenech RJ
Eur J Pharmacol; 1989 Aug; 167(1):67-74. PubMed ID: 2776842
[TBL] [Abstract][Full Text] [Related]
6. Vasoconstrictor effect of endothelin on the canine coronary artery: is a novel endogenous peptide involved in regulating myocardial blood flow and coronary spasm?
Igarashi Y; Aizawa Y; Tamura M; Ebe K; Yamaguchi T; Shibata A
Am Heart J; 1989 Oct; 118(4):674-8. PubMed ID: 2679015
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide Y and sympathetic control of heart contractility and coronary vascular tone.
Franco-Cereceda A; Lundberg JM; Dahlöf C
Acta Physiol Scand; 1985 Jul; 124(3):361-9. PubMed ID: 3840319
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide-Y. A peptide found in human coronary arteries constricts primarily small coronary arteries to produce myocardial ischemia in dogs.
Maturi MF; Greene R; Speir E; Burrus C; Dorsey LM; Markle DR; Maxwell M; Schmidt W; Goldstein SR; Patterson RE
J Clin Invest; 1989 Apr; 83(4):1217-24. PubMed ID: 2703530
[TBL] [Abstract][Full Text] [Related]
9. Effects of neuropeptide Y on coronary artery vasomotion in patients with microvascular angina.
Rosano GMC; Tousoulis D; McFadden E; Clarke J; Davies GJ; Kaski JC
Int J Cardiol; 2017 Jul; 238():123-127. PubMed ID: 28476516
[TBL] [Abstract][Full Text] [Related]
10. The vasoconstrictor effect of neuropeptide Y and related peptides in the guinea pig isolated heart.
Rioux F; Bachelard H; Martel JC; St-Pierre S
Peptides; 1986; 7(1):27-31. PubMed ID: 3754963
[TBL] [Abstract][Full Text] [Related]
11. The effects of neuropeptide Y on myocardial contractility and coronary blood flow.
Awad SJ; Einstein R; Potter EK; Richardson DP
Br J Pharmacol; 1991 Sep; 104(1):195-201. PubMed ID: 1838493
[TBL] [Abstract][Full Text] [Related]
12. Transmural regulation of myocardial perfusion by neuropeptide Y.
Gutterman DD; Morgan DA
Basic Res Cardiol; 1995; 90(4):348-55. PubMed ID: 8534260
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
Lundberg JM; Modin A
Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
[TBL] [Abstract][Full Text] [Related]
14. Interference of angiotensin-converting enzyme inhibition with vasoactive peptides in the coronary circulation of dogs.
Bauer B; Neubauer S; Spindler M; Dürr R; Becker HH; Ertl G
J Cardiovasc Pharmacol; 1995 May; 25(5):756-62. PubMed ID: 7630154
[TBL] [Abstract][Full Text] [Related]
15. Influence of inhibition of endothelium-derived nitric oxide formation to effects of vasoconstrictor agents neuropeptide Y, clonidine, and ergonovine on coronary vascular resistance.
Tsunoda R; Okumura K; Ishizaka H; Matsunaga T; Yasue H
J Cardiovasc Pharmacol; 1994 Jul; 24(1):87-94. PubMed ID: 7521496
[TBL] [Abstract][Full Text] [Related]
16. Effects of neuropeptide Y on regulation of blood flow rate in canine myocardium.
Svendsen JH; Sheikh SP; Jørgensen J; Mikkelsen JD; Paaske WP; Sejrsen P; Haunsø S
Am J Physiol; 1990 Dec; 259(6 Pt 2):H1709-17. PubMed ID: 2260698
[TBL] [Abstract][Full Text] [Related]
17. Adenosine receptor blockade with 8-p-sulfophenyltheophylline aggravates coronary constriction.
Martin SE; Tidmore WC; Patterson RE
Am J Physiol; 1991 Jun; 260(6 Pt 2):H1753-9. PubMed ID: 2058714
[TBL] [Abstract][Full Text] [Related]
18. Effects of neurotensin and neuropeptide Y on coronary circulation and myocardial function in dogs.
Ertl G; Bauer B; Becker HH; Rose G
Am J Physiol; 1993 Apr; 264(4 Pt 2):H1062-8. PubMed ID: 8476083
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y modulates vasoconstriction in coronary microvessels in the beating canine heart.
Komaru T; Ashikawa K; Kanatsuka H; Sekiguchi N; Suzuki T; Takishima T
Circ Res; 1990 Nov; 67(5):1142-51. PubMed ID: 2225353
[TBL] [Abstract][Full Text] [Related]
20. Studies on cardiac distribution and function of neuropeptide Y.
Allen JM; Gjörstrup P; Björkman JA; Ek L; Abrahamsson T; Bloom SR
Acta Physiol Scand; 1986 Mar; 126(3):405-11. PubMed ID: 3754377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
